Peacock Jonathan M 4
4 · Bellerophon Therapeutics, Inc. · Filed Apr 2, 2021
Insider Transaction Report
Form 4
Peacock Jonathan M
DirectorPresident and CEO
Transactions
- Award
Common Stock
2021-03-31+15,308→ 157,033 total
Footnotes (1)
- [F1]RSAs fully vested on grant date.